Clinical Trials · NCT03225209

Medically Reproducing Bariatric Surgery

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Moahad S Dar
Enrollment
5
Start date
Jan 2018
Locations
1 site, United States
Primary endpoint
Change in Glycemic control
View Liraglutide compound reference